Prior exposure to coronaviruses that cause ordinary colds can boost the immune system’s ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill Cornell Medicine.
Among preterm newborns, greater exposure to the mother’s voice after birth appeared to speed up the maturation of a key language-related brain circuit.
Cornell historian Corey Earle shared stories of remarkable women throughout Cornell’s history during an Oct. 25 brunch as part of the Trustee Council Annual Meeting.
Cellular changes that appear during melanoma and lead to treatment resistance can be reversed with drugs – potentially opening the door to new or more effective treatments for the deadly disease, according to new Cornell research.
In 2025, four companies with Cornell-originated technologies — SafetyStratus, Bactana Corporation, Guard Medical and Halo Labs — were acquired by global corporate partners, allowing Cornell technologies to reach broader markets.
Cornell researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt, yet it can wirelessly transmit brain activity data in a living animal for more than a year.
Drug-injury ads are a way for law firms to obtain clients, but when people who need these drugs see the ads, they sometimes stop taking their medication, which can have serious negative consequences, a Cornell researcher found.
Song Lin and collaborators use electrochemistry to selectively synthesize chiral compounds – important in pharmaceuticals – using the reaction’s electrolytes, a completely new strategy.